相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
Susanne Ostrowitzki et al.
ARCHIVES OF NEUROLOGY (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease
Christine Sattler et al.
PSYCHIATRY RESEARCH (2012)
Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of β-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis
Jacqueline L. Grant et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
National estimates of the prevalence of Alzheimer's disease in the United States
Ron Brookmeyer et al.
ALZHEIMERS & DEMENTIA (2011)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Resolving controversies on the path to Alzheimer's therapeutics
Dennis J. Selkoe
NATURE MEDICINE (2011)
Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview
John C. Morris et al.
NEUROBIOLOGY OF AGING (2011)
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Todd E. Golde et al.
NEURON (2011)
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Alzheimer's Disease: The Challenge of the Second Century
David M. Holtzman et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Testing the Right Target and Right Drug at the Right Stage
Reisa A. Sperling et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
Randall J. Bateman et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
The secretases: enzymes with therapeutic potential in Alzheimer disease
Bart De Strooper et al.
NATURE REVIEWS NEUROLOGY (2010)
Alzheimer Disease: Multiple Causes, Multiple Effects of Apolipoprotein E4, and Multiple Therapeutic Approaches
Robert W. Mahley et al.
ANNALS OF NEUROLOGY (2009)
Decreased Cerebrospinal Fluid Aβ42 Correlates with Brain Atrophy in Cognitively Normal Elderly
Anne M. Fagan et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease - A randomized trial
Nicola T. Lautenschlager et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms
David A. Costa et al.
NEUROBIOLOGY OF AGING (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease
Susanne A. Wolf et al.
BIOLOGICAL PSYCHIATRY (2006)
Leisure activities and the risk of amnestic mild cognitive impairment in the elderly
J Verghese et al.
NEUROLOGY (2006)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: A longitudinal study from the kungsholmen project
HX Wang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
分享论文
